Clik here to view.
Journey to the Center of the Brain
That’s the potential of a revolutionary new technology known as Deep Transcranial Magnetic Stimulation, or Deep TMS, being developed by Israel-based Brainsway (TASE:BRIN). Brainsway has a world-wide...
View ArticleClik here to view.
Brainsway receives Frost & Sullivan 2012 innovation award
Brainsway (TASE:BRIN) has received the Frost & Sullivan 2012 Global New Product Innovation Award in neuro-psychiatric devices for its Deep TMS system. “Brainsway’s deep Transcranial Magnetic...
View ArticleClik here to view.
Brainsway’s Deep TMS “a beacon of hope” for depression patients
Brainsway (TASE:BRIN) plans to submit an application by the end of the second quarter this year to the FDA for marketing approval of its deep transcranial magnetic stimulation (Deep TMS) with its...
View ArticleClik here to view.
FDA clears Brainsway’s Deep TMS to treat depression
The FDA has approved Brainsway’s (TASE:BRIN) Deep TMS (transcranial magnetic stimulation) device for the treatment of depression in patients who fail to respond to medication. In a statement, the...
View ArticleClik here to view.
Brainsway’s N American commercialization plans garner media attention
Uzi Sofer Brainsway (TASE:BRIN) CEO Uzi Sofer was interviewed by Reuters and Bloomberg newswires in the wake of decisions by the FDA on Jan. 10 and Health Canada on Jan. 15 to approve the company’s...
View ArticleBrainsway to launch Deep TMS in the U.S.
After completing production of approximately 100 Deep TMS systems, Brainsway (TASE:BRIN) intends to initiate U.S. commercial sales of the device within the next few days, with the official marketing...
View ArticleClik here to view.
Brainsway continues to attract U.S. media attention
An article in the New York Times has highlighted Brainsway (TASE:BRIN) and its deep transcranial magnetic stimulation (Deep TMS) technology, involving magnetic pulses to stimulate parts of the brain...
View Article
